Bracco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRACCO, and when can generic versions of BRACCO drugs launch?
BRACCO has forty approved drugs.
There are three US patents protecting BRACCO drugs.
There are thirty-four patent family members on BRACCO drugs in twelve countries and seventy-three supplementary protection certificates in eight countries.
Drugs and US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | ISOVUE-200 | iopamidol | INJECTABLE;INJECTION | 018735-006 | Jul 7, 1987 | AP2 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | VARIBAR NECTAR | barium sulfate | SUSPENSION;ORAL | 208143-004 | Jul 7, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Bracco | CHROMITOPE SODIUM | sodium chromate cr-51 | INJECTABLE;INJECTION | 013993-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bracco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | ISOVUE-300 | iopamidol | INJECTABLE;INJECTION | 018735-002 | Dec 31, 1985 | 4,001,323 | ⤷ Try a Trial |
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | 6,803,046 | ⤷ Try a Trial |
Bracco | MULTIHANCE | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021357-003 | Nov 23, 2004 | 4,916,246 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bracco Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2020276679 | ⤷ Try a Trial |
South Africa | 202108096 | ⤷ Try a Trial |
Singapore | 11202111756U | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bracco Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1178838 | 300736 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119 |
1556389 | 92943 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CEFTOLOZANE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, EN PARTICULIER UN SEL D'ACIDE SULFURIQUE (ZERBAXA); FIRST REGISTRATION: 20150922 |
1856135 | CA 2020 00018 | Denmark | ⤷ Try a Trial | PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.